Q3 2026 Artemis Medicare Services Ltd Earnings Call Transcript
Key Points
- Artemis Medicare Services Ltd (BOM:542919) reported a consolidated revenue growth of 17.2% year-on-year for the third quarter, driven by strong performance across core specialties and improved payer mix.
- The company achieved an EBITDA of INR52 crores with a margin of 9.1%, reflecting improved operational efficiencies and disciplined cost management.
- International patient revenue grew by 34.9%, contributing to 34% of total revenues, highlighting the company's strong position in the medical tourism segment.
- Artemis Medicare Services Ltd (BOM:542919) is on track to expand its capacity to 2000+ beds by 2029, with new facilities in Raipur and South Delhi expected to enhance its service offerings.
- The company received a platinum green building certification, allowing for an expansion of 100 to 125 more beds at its Gurugram facility at no extra cost.
- The occupancy rate at the flagship facility in Gurugram was 62%, which is below the targeted 70% occupancy rate.
- There is a delay in the commissioning of the new 300-bed super specialty hospital in Raipur, now expected to begin operations in April-May 2026 instead of March 2026.
- The company plans to raise INR700 crores through QIPs, which may lead to equity dilution.
- Employee costs have increased, impacting margins, although this is expected to stabilize as occupancy rates improve.
- The cardiac care and daffodils segments have shown subdued performance, with efforts being made to improve realization and change the patient mix.
Ladies and gentlemen, good day and welcome to the Artemis Medicare conference call for the three and nine months FY26 results. (Operator Instructions)
I now hand the conference over to Ms. Deepika Muraka from Choice Equity Broking. Thank you and over to you, ma'am.
Thank you. Good morning all. On behalf of the entire management, I thank all the participants present on the call, and I wish you a warm welcome to the earnings conference call of Artemis Medicare Services Limited.
To guide us through the results today, we have with our senior management team of RMS Medicare, presented by Dr. Devlina Chakravarty, Managing Director; Mr. Sanjiv Kumar Kothari, CFO; Dr. Vishal Arora, Chief Business Officer; and Rudra Narayan, Head IR.
Before we begin, please note that this conference call may contain certain forward-looking statements about the company, which are based on the beliefs, opinion and expectation of the company as on the date of this call. These statements are not a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
